Mucosal Immunity Related to FOXP3⁺Regulatory T Cells, Th17 Cells and Cytokines in Pediatric Inflammatory Bowel Disease

Abstract

BackgroundWe aimed to investigate mucosal immunity related to forkhead box P3 (FOXP3+) regulatory T (Treg) cells, T helper 17 (Th17) cells and cytokines in pediatric inflammatory bowel disease (IBD).MethodsMucosal tissues from terminal ileum and colon and serum samples were collected from twelve children with IBD and seven control children. Immunohistochemical staining was done using anti-human FOXP3 and anti-RORγt antibodies. Serum levels of cytokines were analyzed using a multiplex assay covering interleukin (IL)-1β, IL-4, IL-6, IL-10, IL-17A/F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33, interferon (IFN)-γ, soluble CD40L, and tumor necrosis factor-α.ResultsFOXP3+ Treg cells in the lamina propria (LP) of terminal ileum of patients with Crohn's disease were significantly (P < 0.05) higher than those in the healthy controls. RORγt+ T cells of terminal ileum tended to be higher in Crohn's disease than those in the control. In the multiplex assay, serum concentrations (pg/mL) of IL-4 (9.6 ± 1.5 vs. 12.7 ± 3.0), IL-21 (14.9 ± 1.5 vs. 26.4 ± 9.1), IL-33 (14.3 ± 0.9 vs. 19.1 ± 5.3), and IFN-γ (15.2 ± 5.9 vs. 50.2 ± 42.4) were significantly lower in Crohn's disease than those in the control group. However, serum concentration of IL-6 (119.1 ± 79.6 vs. 52.9 ± 39.1) was higher in Crohn's disease than that in the control. Serum concentrations of IL-17A (64.2 ± 17.2 vs. 28.3 ± 10.0) and IL-22 (37.5 ± 8.8 vs. 27.2 ± 3.7) were significantly higher in ulcerative colitis than those in Crohn's disease.ConclusionMucosal immunity analysis showed increased FOXP3+ T reg cells in the LP with Crohn's disease while Th17 cell polarizing and signature cytokines were decreased in the serum samples of Crohn's disease but increased in ulcerative colitis.

Sishen Pill Treatment of DSS-Induced Colitis via Regulating Interaction With Inflammatory Dendritic Cells and Gut Microbiota

“…It is reported that IL-4 can induce differentiation of naïve CD4 + T cells into Th2 cells, and Th2 cells secrete IL-9 that acts as a pro-inflammatory factor that affects intestinal mucosal integrity by impairing intestinal barrier function (Bieber et al, 2017). In addition, IL-9 can induce differentiation of cells into Th9 cells in the presence of IL-4, and IL-17 is also a characteristic cytokine of Th17 cells (Cho et al, 2018). TNF-α plays an important role in inflammatory cell activation and epithelial cell permeability.…”

Tryptophan Metabolism, Regulatory T Cells, and Inflammatory Bowel Disease: A Mini Review

“…Mechanistically, Tregs could be considered as therapeutic targets for controlling IBD (Figure 1). Fortunately, many cases of IBD have been successfully cured or alleviated by manipulating Tregs in animal models or patients [45][46][47][48][49][50][51][52][53][54][55][56]. For example, Treg transfer is sufficient to alleviate experimental colitis including IBD, and tTregs and iTregs can work together [57][58][59][60].…”

Aryl Hydrocarbon Receptor Activation Ameliorates Experimental Colitis by Modulating the Tolerogenic Dendritic and Regulatory T Cell Formation

“…While the Th17 cells have important implications in autoimmune diseases, the Treg cells control the autoimmune reactivities (2). Mechanically, the frequency of Th17 cells was increased, while that of Treg cells was decreased in the intestinal mucosa of CD patients (3). Previous studies have demonstrated that an imbalance of Th17 and Treg cells is associated with the development of CD (4,5).…”